Fortress Biotech Stock Performance

FBIO Stock  USD 3.27  0.34  11.60%   
On a scale of 0 to 100, Fortress Biotech holds a performance score of 8. The firm shows a Beta (market volatility) of 2.29, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fortress Biotech will likely underperform. Please check Fortress Biotech's semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Fortress Biotech's price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
11.6
Five Day Return
4.47
Year To Date Return
(18.86)
Ten Year Return
(91.84)
All Time Return
(98.02)
Last Split Factor
1:15
Last Split Date
2023-10-10
1
Fortress Government Solutions Secures Strategic IDIQ Contract to Revolutionize the Navys Cyber Supply Chain Defense
11/20/2025
2
Why Russia Wont Agree to Peace Without Ukraines Fortress Belt
12/05/2025
3
Fortress Real Estate Investments Limiteds Stock Has Shown Weakness Lately But Financial Prospects Look Decent Is The Market Wrong
12/23/2025
4
Fortress Wealth Management Inc. Decreases Stake in NEOS SP 500 High Income ETF SPYI
12/26/2025
5
New Fortress Falls 5 percent on Credit Concerns
12/31/2025
6
Here is Why New Fortress Energy Fell This Week
01/02/2026
7
Fortress Minerals Margin Compression Reinforces Cautious Earnings Narratives After Q3 2026 Results
01/09/2026
8
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO , the First and Only Approved Treatment for Menkes Disease in the United States
01/13/2026
9
Fortress Biotech Stock Price Crosses Above 200 Day Moving Average - Heres What Happened - MarketBeat
01/23/2026
10
Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
02/02/2026
11
Market Cool On Fortress Biotech, Inc.s Revenues Pushing Shares 28 percent Lower
02/05/2026
Begin Period Cash Flow83.4 M
Total Cashflows From Investing Activities-15 M

Fortress Biotech Relative Risk vs. Return Landscape

If you would invest  259.00  in Fortress Biotech on November 10, 2025 and sell it today you would earn a total of  68.00  from holding Fortress Biotech or generate 26.25% return on investment over 90 days. Fortress Biotech is currently generating 0.4864% in daily expected returns and assumes 4.7108% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than Fortress, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Fortress Biotech is expected to generate 5.8 times more return on investment than the market. However, the company is 5.8 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Fortress Biotech Target Price Odds to finish over Current Price

The tendency of Fortress Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.27 90 days 3.27 
about 43.5
Based on a normal probability distribution, the odds of Fortress Biotech to move above the current price in 90 days from now is about 43.5 (This Fortress Biotech probability density function shows the probability of Fortress Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.29 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Fortress Biotech will likely underperform. Additionally Fortress Biotech has an alpha of 0.3562, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Fortress Biotech Price Density   
       Price  

Predictive Modules for Fortress Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fortress Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.173.398.10
Details
Intrinsic
Valuation
LowRealHigh
0.465.179.88
Details
2 Analysts
Consensus
LowTargetHigh
9.7810.7511.93
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.020.080.18
Details

Fortress Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Fortress Biotech is not an exception. The market had few large corrections towards the Fortress Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fortress Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fortress Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.36
β
Beta against Dow Jones2.29
σ
Overall volatility
0.55
Ir
Information ratio 0.10

Fortress Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fortress Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fortress Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Fortress Biotech had very high historical volatility over the last 90 days
Fortress Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 57.67 M. Net Loss for the year was (120.86 M) with profit before overhead, payroll, taxes, and interest of 19.93 M.
Fortress Biotech currently holds about 208.35 M in cash with (80.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Fortress Biotech has a very weak financial position based on the latest SEC disclosures
Roughly 20.0% of the company shares are held by company insiders
Latest headline from simplywall.st: Market Cool On Fortress Biotech, Inc.s Revenues Pushing Shares 28 percent Lower

Fortress Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fortress Stock often depends not only on the future outlook of the current and potential Fortress Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fortress Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.8 M
Cash And Short Term Investments57.3 M

Fortress Biotech Fundamentals Growth

Fortress Stock prices reflect investors' perceptions of the future prospects and financial health of Fortress Biotech, and Fortress Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fortress Stock performance.

About Fortress Biotech Performance

By examining Fortress Biotech's fundamental ratios, stakeholders can obtain critical insights into Fortress Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Fortress Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 227.05  238.40 
Return On Tangible Assets(0.37)(0.39)
Return On Capital Employed(1.74)(1.66)
Return On Assets(0.29)(0.30)
Return On Equity(2.33)(2.44)

Things to note about Fortress Biotech performance evaluation

Checking the ongoing alerts about Fortress Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fortress Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Fortress Biotech had very high historical volatility over the last 90 days
Fortress Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 57.67 M. Net Loss for the year was (120.86 M) with profit before overhead, payroll, taxes, and interest of 19.93 M.
Fortress Biotech currently holds about 208.35 M in cash with (80.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Fortress Biotech has a very weak financial position based on the latest SEC disclosures
Roughly 20.0% of the company shares are held by company insiders
Latest headline from simplywall.st: Market Cool On Fortress Biotech, Inc.s Revenues Pushing Shares 28 percent Lower
Evaluating Fortress Biotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Fortress Biotech's stock performance include:
  • Analyzing Fortress Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fortress Biotech's stock is overvalued or undervalued compared to its peers.
  • Examining Fortress Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Fortress Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fortress Biotech's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Fortress Biotech's stock. These opinions can provide insight into Fortress Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Fortress Biotech's stock performance is not an exact science, and many factors can impact Fortress Biotech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Will Biotechnology sector continue expanding? Could Fortress diversify its offerings? Factors like these will boost the valuation of Fortress Biotech. Market participants price Fortress higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fortress Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.12)
Revenue Per Share
2.324
Quarterly Revenue Growth
0.205
Return On Assets
(0.34)
Return On Equity
(2.05)
Fortress Biotech's market price often diverges from its book value, the accounting figure shown on Fortress's balance sheet. Smart investors calculate Fortress Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Fortress Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.